United States Pharmaceuticals

Vericel Corp (VCEL)

Track

Track

Vericel Corp experienced twenty-four insider trading transactions over the past ninety days, totaling approximately 7.97 million dollars in sales. Key executives, including the Chief Operating Officer and Chief Financial Officer, offloaded shares following a positive earnings report. These divestments occurred amidst stable stock performance, reflecting systematic liquidation rather than acquisition activity.
Ticker: VCEL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vericel Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
228.87
Quantity 69,351 -15.2%
Value US$3,522,280
0.6
MCLAUGHLIN KEVIN F Director Non-Executive Director
Transaction date
Proposed sale
Price
183.38
Quantity 7,250
Value US$4,494,282
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
303.94
Quantity 84,258 -41.1%
Value US$2,742,896
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
45.98
Quantity 10,000
Value US$459,800
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
48.90
Quantity 500 -31.7%
Value US$24,450
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
48.90
Quantity 2,500 -69.9%
Value US$122,250
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
48.90
Quantity 1,500 -58.2%
Value US$73,350
SIEGAL JONATHAN Officer Officer
Transaction date
Proposed sale
Price
48.90
Quantity 4,500
Value US$220,050
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
44.90
Quantity 2,500 -73.8%
Value US$112,250
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
44.90
Quantity 232 -20.8%
Value US$10,417
Flynn Sean C. Chief Legal Officer Officer
Transaction date
Planned sale
Price
45.64
Quantity 15,000 -90.1%
Value US$684,600
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.00
Quantity 5,000 -6.2%
Value US$225,000
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.00
Quantity 5,000 -6.2%
Value US$225,000
Mara Joseph Anthony Jr Chief Financial Officer Officer
Transaction date
Planned sale
Price
44.75
Quantity 5,000 -23.8%
Value US$223,750
Flynn Sean C. Officer Officer
Transaction date
Proposed sale
Price
45.64
Quantity 15,000
Value US$684,659
Mara Joseph Anthony Jr Officer Officer
Transaction date
Proposed sale
Price
44.75
Quantity 5,000
Value US$223,750
SIEGAL JONATHAN Officer Officer
Transaction date
Proposed sale
Price
44.90
Quantity 2,732
Value US$122,667
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
45.00
Quantity 10,000
Value US$450,000
Flynn Sean C. Chief Legal Officer Officer
Transaction date
Planned sale
Price
40.21
Quantity 15,000 -90.1%
Value US$603,150
Flynn Sean C. Chief Legal Officer Officer
Transaction date
Planned sale
Price
40.21
Quantity 15,000 -90.1%
Value US$603,150
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.24
Quantity 10,000 -38.1%
Value US$402,400
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.24
Quantity 10,000 -38.1%
Value US$402,400
Flynn Sean C. Officer Officer
Transaction date
Proposed sale
Price
40.21
Quantity 15,000
Value US$603,148
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
40.24
Quantity 10,000
Value US$402,401
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.00
Quantity 4,375 -5.5%
Value US$153,125
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
35.00
Quantity 4,375
Value US$153,125
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
32.82
Quantity 3,500 -16.1%
Value US$114,870
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
32.83
Quantity 3,500 -16.1%
Value US$114,905
0.6
MCLAUGHLIN KEVIN F Director Non-Executive Director
Transaction date
Proposed sale
Price
32.57
Quantity 7,000
Value US$227,990
2.4
Wotton Paul K Non-Executive Director
Transaction date
Sale
Price
32.64
Quantity 7,500 -28.5%
Value US$244,800
2.4
Wotton Paul K Non-Executive Director
Transaction date
Sale
Price
33.05
Quantity 2,500 -8.7%
Value US$82,625
2.4
Wotton Paul K Director Non-Executive Director
Transaction date
Proposed sale
Price
32.74
Quantity 10,000
Value US$327,425
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
40.50
Quantity 1,422 -56.0%
Value US$57,591
Mara Joseph Anthony Jr Chief Financial Officer Officer
Transaction date
Planned sale
Price
40.50
Quantity 5,000 -19.2%
Value US$202,500
SIEGAL JONATHAN Officer Officer
Transaction date
Proposed sale
Price
40.50
Quantity 1,422
Value US$57,591
Mara Joseph Anthony Jr Officer Officer
Transaction date
Proposed sale
Price
40.50
Quantity 5,000
Value US$202,500
SIEGAL JONATHAN Principal Accounting Officer Officer
Transaction date
Planned sale
Price
38.00
Quantity 3,433 -57.5%
Value US$130,454
SIEGAL JONATHAN Officer Officer
Transaction date
Proposed sale
Price
38.00
Quantity 3,433
Value US$130,454
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.00
Quantity 3,472 -4.4%
Value US$121,520
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
35.00
Quantity 3,472
Value US$121,520
Hagen Heidi Non-Executive Director
Transaction date
Planned sale
Price
32.41
Quantity 15,000 -32.0%
Value US$486,150
Hagen Heidi Director Non-Executive Director
Transaction date
Proposed sale
Price
32.41
Quantity 15,000
Value US$486,163
Flynn Sean C. Chief Legal Officer Officer
Transaction date
Planned sale
Price
35.36
Quantity 15,000 -92.2%
Value US$530,400
Flynn Sean C. Chief Legal Officer Officer
Transaction date
Planned sale
Price
34.75
Quantity 6,421 -83.6%
Value US$223,130
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
35.30
Quantity 10,305 -39.1%
Value US$363,766
Flynn Sean C. Officer Officer
Transaction date
Proposed sale
Price
35.18
Quantity 21,421
Value US$753,509
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
35.30
Quantity 10,305
Value US$363,749
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
34.66
Quantity 7,000 -31.7%
Value US$242,620
0.6
MCLAUGHLIN KEVIN F Director Non-Executive Director
Transaction date
Proposed sale
Price
35.62
Quantity 7,000
Value US$249,340
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.48
Quantity 10,000 -38.3%
Value US$404,800
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
40.48
Quantity 10,000
Value US$404,833
2.4
Wotton Paul K Non-Executive Director
Transaction date
Sale
Price
37.83
Quantity 2,500 -8.9%
Value US$94,575
2.4
Wotton Paul K Director Non-Executive Director
Transaction date
Proposed sale
Price
37.83
Quantity 2,500
Value US$94,575
2.4
Wotton Paul K Non-Executive Director
Transaction date
Sale
Price
37.97
Quantity 2,500 -8.2%
Value US$94,925
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
39.14
Quantity 1,652 -2.4%
Value US$64,659
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
39.14
Quantity 1,652
Value US$64,659
2.4
Wotton Paul K Director Non-Executive Director
Transaction date
Proposed sale
Price
37.97
Quantity 2,500
Value US$94,919
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.41
Quantity 2,642 -14.2%
Value US$106,763
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
40.41
Quantity 2,642
Value US$106,760
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
38.59
Quantity 7,000 -31.7%
Value US$270,130
0.6
MCLAUGHLIN KEVIN F Director Non-Executive Director
Transaction date
Proposed sale
Price
39.71
Quantity 7,000
Value US$277,970
Halpin Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.47
Quantity 7,358 -31.6%
Value US$297,778
Halpin Michael Officer Officer
Transaction date
Proposed sale
Price
40.47
Quantity 7,358
Value US$297,775
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.77
Quantity 10,000 -13.1%
Value US$357,700
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
35.77
Quantity 10,000
Value US$357,700
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
35.92
Quantity 7,000 -31.7%
Value US$251,440
0.6
MCLAUGHLIN KEVIN F Director Non-Executive Director
Transaction date
Proposed sale
Price
35.92
Quantity 7,000
Value US$251,457
Hopper Jonathan Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
40.09
Quantity 10,000 -13.1%
Value US$400,900
Hopper Jonathan Mark Officer Officer
Transaction date
Proposed sale
Price
41.13
Quantity 10,000
Value US$411,300
3.2
GILMAN STEVEN C Former Director Non-Executive Director
Transaction date
Proposed sale
Price
42.00
Quantity 13,125
Value US$551,250
Colangelo Dominick President and CEO Executive Director
Transaction date
Planned sale
Price
41.53
Quantity 14,063 -5.1%
Value US$584,036
Colangelo Dominick Officer; Director Executive Director
Transaction date
Proposed sale
Price
42.26
Quantity 14,063
Value US$594,302
Colangelo Dominick President and CEO Executive Director
Transaction date
Planned sale
Price
42.25
Quantity 14,062 -5.1%
Value US$594,120
Colangelo Dominick Officer; Director Executive Director
Transaction date
Proposed sale
Price
43.29
Quantity 14,062
Value US$608,744
0.6
MCLAUGHLIN KEVIN F Non-Executive Director
Transaction date
Planned sale
Price
39.98
Quantity 7,000 -31.7%
Value US$279,860
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-12 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
69,351 -15.2%
228.87
US$3,522,280 		69,351 -15.2% 228.87 US$3,522,280
2026-08-12 2026-08-12 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,250
183.38
US$4,494,282 		7,250 183.38 US$4,494,282
2026-08-05 2026-08-03 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
84,258 -41.1%
303.94
US$2,742,896 		84,258 -41.1% 303.94 US$2,742,896
2026-08-03 2026-08-03 PrS Proposed sale
Halpin Michael

Officer

Officer
10,000
45.98
US$459,800 		10,000 45.98 US$459,800
2026-07-31 2026-07-30 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
500 -31.7%
48.90
US$24,450 		500 -31.7% 48.90 US$24,450
2026-07-31 2026-07-30 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
2,500 -69.9%
48.90
US$122,250 		2,500 -69.9% 48.90 US$122,250
2026-07-31 2026-07-30 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
1,500 -58.2%
48.90
US$73,350 		1,500 -58.2% 48.90 US$73,350
2026-07-30 2026-07-30 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
4,500
48.90
US$220,050 		4,500 48.90 US$220,050
2026-06-30 2026-06-26 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
2,500 -73.8%
44.90
US$112,250 		2,500 -73.8% 44.90 US$112,250
2026-06-30 2026-06-26 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
232 -20.8%
44.90
US$10,417 		232 -20.8% 44.90 US$10,417
2026-06-30 2026-06-26 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
15,000 -90.1%
45.64
US$684,600 		15,000 -90.1% 45.64 US$684,600
2026-06-30 2026-06-26 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
5,000 -6.2%
45.00
US$225,000 		5,000 -6.2% 45.00 US$225,000
2026-06-30 2026-06-26 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
5,000 -6.2%
45.00
US$225,000 		5,000 -6.2% 45.00 US$225,000
2026-06-30 2026-06-26 PlS Planned sale
Mara Joseph Anthony Jr

Chief Financial Officer

Officer
5,000 -23.8%
44.75
US$223,750 		5,000 -23.8% 44.75 US$223,750
2026-06-26 2026-06-26 PrS Proposed sale
Flynn Sean C.

Officer

Officer
15,000
45.64
US$684,659 		15,000 45.64 US$684,659
2026-06-26 2026-06-26 PrS Proposed sale
Mara Joseph Anthony Jr

Officer

Officer
5,000
44.75
US$223,750 		5,000 44.75 US$223,750
2026-06-26 2026-06-26 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
2,732
44.90
US$122,667 		2,732 44.90 US$122,667
2026-06-26 2026-06-26 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
45.00
US$450,000 		10,000 45.00 US$450,000
2026-06-22 2026-06-18 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
15,000 -90.1%
40.21
US$603,150 		15,000 -90.1% 40.21 US$603,150
2026-06-22 2026-06-18 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
15,000 -90.1%
40.21
US$603,150 		15,000 -90.1% 40.21 US$603,150
2026-06-22 2026-06-18 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,000 -38.1%
40.24
US$402,400 		10,000 -38.1% 40.24 US$402,400
2026-06-22 2026-06-18 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,000 -38.1%
40.24
US$402,400 		10,000 -38.1% 40.24 US$402,400
2026-06-18 2026-06-18 PrS Proposed sale
Flynn Sean C.

Officer

Officer
15,000
40.21
US$603,148 		15,000 40.21 US$603,148
2026-06-18 2026-06-18 PrS Proposed sale
Halpin Michael

Officer

Officer
10,000
40.24
US$402,401 		10,000 40.24 US$402,401
2026-06-04 2026-06-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
4,375 -5.5%
35.00
US$153,125 		4,375 -5.5% 35.00 US$153,125
2026-06-02 2026-06-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
4,375
35.00
US$153,125 		4,375 35.00 US$153,125
2026-05-15 2026-05-13 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
3,500 -16.1%
32.82
US$114,870 		3,500 -16.1% 32.82 US$114,870
2026-05-15 2026-05-13 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
3,500 -16.1%
32.83
US$114,905 		3,500 -16.1% 32.83 US$114,905
2026-05-13 2026-05-13 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
32.57
US$227,990 		7,000 32.57 US$227,990
2026-05-13 2026-05-11 S Sale
2.4
Wotton Paul K
Non-Executive Director
7,500 -28.5%
32.64
US$244,800 		7,500 -28.5% 32.64 US$244,800
2026-05-13 2026-05-11 S Sale
2.4
Wotton Paul K
Non-Executive Director
2,500 -8.7%
33.05
US$82,625 		2,500 -8.7% 33.05 US$82,625
2026-05-11 2026-05-11 PrS Proposed sale
2.4
Wotton Paul K

Director

Non-Executive Director
10,000
32.74
US$327,425 		10,000 32.74 US$327,425
2026-05-08 2026-05-07 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
1,422 -56.0%
40.50
US$57,591 		1,422 -56.0% 40.50 US$57,591
2026-05-08 2026-05-07 PlS Planned sale
Mara Joseph Anthony Jr

Chief Financial Officer

Officer
5,000 -19.2%
40.50
US$202,500 		5,000 -19.2% 40.50 US$202,500
2026-05-07 2026-05-07 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
1,422
40.50
US$57,591 		1,422 40.50 US$57,591
2026-05-07 2026-05-07 PrS Proposed sale
Mara Joseph Anthony Jr

Officer

Officer
5,000
40.50
US$202,500 		5,000 40.50 US$202,500
2026-05-08 2026-05-06 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
3,433 -57.5%
38.00
US$130,454 		3,433 -57.5% 38.00 US$130,454
2026-05-06 2026-05-06 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
3,433
38.00
US$130,454 		3,433 38.00 US$130,454
2026-04-06 2026-04-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
3,472 -4.4%
35.00
US$121,520 		3,472 -4.4% 35.00 US$121,520
2026-04-02 2026-04-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
3,472
35.00
US$121,520 		3,472 35.00 US$121,520
2026-03-25 2026-03-23 PlS Planned sale
Hagen Heidi
Non-Executive Director
15,000 -32.0%
32.41
US$486,150 		15,000 -32.0% 32.41 US$486,150
2026-03-23 2026-03-23 PrS Proposed sale
Hagen Heidi

Director

Non-Executive Director
15,000
32.41
US$486,163 		15,000 32.41 US$486,163
2026-03-04 2026-03-02 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
15,000 -92.2%
35.36
US$530,400 		15,000 -92.2% 35.36 US$530,400
2026-03-04 2026-03-02 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
6,421 -83.6%
34.75
US$223,130 		6,421 -83.6% 34.75 US$223,130
2026-03-04 2026-03-02 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,305 -39.1%
35.30
US$363,766 		10,305 -39.1% 35.30 US$363,766
2026-03-02 2026-03-02 PrS Proposed sale
Flynn Sean C.

Officer

Officer
21,421
35.18
US$753,509 		21,421 35.18 US$753,509
2026-03-02 2026-03-02 PrS Proposed sale
Halpin Michael

Officer

Officer
10,305
35.30
US$363,749 		10,305 35.30 US$363,749
2026-02-13 2026-02-11 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
34.66
US$242,620 		7,000 -31.7% 34.66 US$242,620
2026-02-11 2026-02-11 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
35.62
US$249,340 		7,000 35.62 US$249,340
2026-01-09 2026-01-07 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,000 -38.3%
40.48
US$404,800 		10,000 -38.3% 40.48 US$404,800
2026-01-07 2026-01-07 PrS Proposed sale
Halpin Michael

Officer

Officer
10,000
40.48
US$404,833 		10,000 40.48 US$404,833
2025-12-04 2025-12-03 S Sale
2.4
Wotton Paul K
Non-Executive Director
2,500 -8.9%
37.83
US$94,575 		2,500 -8.9% 37.83 US$94,575
2025-12-03 2025-12-03 PrS Proposed sale
2.4
Wotton Paul K

Director

Non-Executive Director
2,500
37.83
US$94,575 		2,500 37.83 US$94,575
2025-12-04 2025-12-02 S Sale
2.4
Wotton Paul K
Non-Executive Director
2,500 -8.2%
37.97
US$94,925 		2,500 -8.2% 37.97 US$94,925
2025-12-04 2025-12-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
1,652 -2.4%
39.14
US$64,659 		1,652 -2.4% 39.14 US$64,659
2025-12-02 2025-12-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
1,652
39.14
US$64,659 		1,652 39.14 US$64,659
2025-12-02 2025-12-02 PrS Proposed sale
2.4
Wotton Paul K

Director

Non-Executive Director
2,500
37.97
US$94,919 		2,500 37.97 US$94,919
2025-11-13 2025-11-11 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
2,642 -14.2%
40.41
US$106,763 		2,642 -14.2% 40.41 US$106,763
2025-11-12 2025-11-11 PrS Proposed sale
Halpin Michael

Officer

Officer
2,642
40.41
US$106,760 		2,642 40.41 US$106,760
2025-11-12 2025-11-10 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
38.59
US$270,130 		7,000 -31.7% 38.59 US$270,130
2025-11-10 2025-11-10 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
39.71
US$277,970 		7,000 39.71 US$277,970
2025-11-10 2025-11-06 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
7,358 -31.6%
40.47
US$297,778 		7,358 -31.6% 40.47 US$297,778
2025-11-06 2025-11-06 PrS Proposed sale
Halpin Michael

Officer

Officer
7,358
40.47
US$297,775 		7,358 40.47 US$297,775
2025-09-03 2025-09-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -13.1%
35.77
US$357,700 		10,000 -13.1% 35.77 US$357,700
2025-09-02 2025-09-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
35.77
US$357,700 		10,000 35.77 US$357,700
2025-08-08 2025-08-06 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
35.92
US$251,440 		7,000 -31.7% 35.92 US$251,440
2025-08-06 2025-08-06 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
35.92
US$251,457 		7,000 35.92 US$251,457
2025-06-04 2025-06-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -13.1%
40.09
US$400,900 		10,000 -13.1% 40.09 US$400,900
2025-06-02 2025-06-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
41.13
US$411,300 		10,000 41.13 US$411,300
2025-05-30 2025-05-30 PrS Proposed sale
3.2
GILMAN STEVEN C

Former Director

Non-Executive Director
13,125
42.00
US$551,250 		13,125 42.00 US$551,250
2025-05-16 2025-05-15 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
14,063 -5.1%
41.53
US$584,036 		14,063 -5.1% 41.53 US$584,036
2025-05-15 2025-05-15 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
14,063
42.26
US$594,302 		14,063 42.26 US$594,302
2025-05-16 2025-05-14 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
14,062 -5.1%
42.25
US$594,120 		14,062 -5.1% 42.25 US$594,120
2025-05-14 2025-05-14 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
14,062
43.29
US$608,744 		14,062 43.29 US$608,744
2025-05-09 2025-05-07 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
39.98
US$279,860 		7,000 -31.7% 39.98 US$279,860
Explore more

More insider trading research around Vericel Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America